Sainte-foy, QC
Infectio Diagnostic est un pionnier du diagnostic molculaire avec deux tests - approuvs par Sant Canada et la FDA - qui rpondent deux cas de diagnostic d'urgence: (1) la dtection directe de la colonisation par le streptocoque B de la femme enceinte au moment de l'accouchement (IDI-Strep BTM) et (ii) la dtection directe de MRSA (Staphylococcus aureus Rsistant la Mticilline) (IDI-MRSATM), la bactrie multirsistante aux antibiotiques la plus dangereuse. Ces produits ont t les premiers rencontrer les spcifications des agences rglementaires pour remplacer les mthodes traditionnelles de dtection des microorganismes par culture. Plusieurs produits sont en dveloppement et comprennent en particulier la dtection de la rsistance la vancomycine.
2050, boul. Ren-Lvesque O., 4e tage
Sainte-foy, QC G1V 2K8
CA
2050, boul. Ren-Lvesque O., 4e tage
Sainte-foy, QC G1V 2K8
CA
Legal Name: Infectio Diagnostic (I. D. I.) Inc.
CA
IDI commercialized its first product IDI-Strep in 2003. The second produt IDI-MRSA should be commercialized by the end of December 2003 in Canada and at the beginning of 2004 in USA. I. D. I. will continue to introduce a series of innovative diagnostic kits in the years to come which will revolutionize infectious disease management due to its genomic technology. Thse DNA based assay kits will provide information about the nature of the infection to physicians within one hour compared to the 2 to 3 days normally required. As a result, this will improve patient care by reducing the quantity of antibiotic prescriptions too often used for no reason and fights against the growing problem of bacterial resistance to antibiotics. These tests are extremely accurate acting like the 'fingerprinting' of the bacteria. They will be flexible and extremely cost effective.
Title: Prsident et chef de direction interim
Phone: Show phone
Fax: Show fax
Email: Show email
Detection of MRSA directly from samples.
Detection of VRE directly from samples.
541710